arthritis: An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1436 |
4. Check minimum number of eventsNone |
1436 |
5. Include endpointsNone |
1436 |
6. Filter based on genotype QC (FinnGen only) |
1436 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M13
- Name in latin
- Polyarthritis NAS
Similar endpoints
↥List of similar endpoints to
Polyarthritis, unspecified
based on the number of shared cases.
Similar with more cases:
- Other arthritis (FG)
- Polyarthropathies
- Finngen Rheumatological endpoints
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9797 | 5674 | 4039 |
| Only index persons | 8477 | 5001 | 3476 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.14 | 0.16 | 0.11 |
| Only index persons | 0.16 | 0.18 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 53.37 | 52.56 | 54.28 |
| Only index persons | 51.86 | 50.97 | 53.15 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1436 | 857 | 579 |
| Unadjusted period prevalence (%) | 0.28 | 0.29 | 0.26 |
| Median age at first event (years) | 51.31 | 47.84 | 56.45 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1321
- Matched controls
- 13210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
102.7
323.0
463
69
A07EC01
ATC
sulfasalazine; oral, rectal
59.9
323.0
554
157
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
63.9
323.0
600
170
M13.9
ICD-10 Finland
Arthritis, unspecified
102.8
323.0
489
75
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
88.9
323.0
433
72
M13.0
ICD-10 Finland
Polyarthritis, unspecified
4503599627370496.0
323.0
1151
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
78.2
323.0
760
225
P01BA02
ATC
hydroxychloroquine; oral
71.7
323.0
527
121
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3571.0
317.7
294
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3032.9
278.0
259
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
146.5
258.6
269
23
H02AB06
ATC
prednisolone; systemic
7.5
240.0
979
3658
M17.1
ICD-10 Finland
Other primary gonarthrosis
20.6
179.7
277
168
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
400.8
179.1
176
5
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
91.5
178.2
196
25
L04AA13
ATC
leflunomide; oral
323.3
170.1
169
6
L88
ICPC
Rheumatoid/seropositive arthritis
60.3
167.5
196
38
M25.5
ICD-10 Finland
Pain in joint
6.6
166.5
513
1151
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
95.9
166.2
182
22
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
12.5
149.7
286
286
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
754.6
140.5
136
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
16.2
134.0
225
165
7165A
ICD-9 Finland
Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis
+∞
126.1
119
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
88.5
115.5
128
16
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
13.2
115.4
212
189
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.9
108.7
618
2418
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
+∞
100.3
95
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
264.2
97.0
98
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
27.2
97.0
135
55
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
13.1
91.5
167
144
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
170.3
91.4
95
6
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
928.4
89.8
87
*
TNG10
NOMESCO Finland
Puncture of knee
+∞
89.6
85
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
32.5
87.5
116
39
M01CB01
ATC
sodium aurothiomalate; parenteral
+∞
86.4
82
*
H02AB07
ATC
prednisone; oral
4.9
84.0
316
802
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
83.8
690
3385
M01AH05
ATC
etoricoxib; oral
3.1
83.4
833
4665
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
105.9
82.0
89
9
L04AB01
ATC
etanercept; parenteral
104.6
81.0
88
9
NH3EA
NOMESCO Finland
Feet X-ray examination with load
99.6
76.9
84
9
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
11.3
75.7
148
146
N02AX02
ATC
tramadol; systemic, rectal
3.0
74.4
611
2915
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
102.1
70.7
77
8
L04AB04
ATC
adalimumab; parenteral
33.2
70.7
93
30
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
80.6
67.8
76
10
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
26.9
66.9
93
37
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
147.6
66.6
70
5
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
24.6
65.9
94
41
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
231.2
64.8
66
*
M10.9
ICD-10 Finland
Gout, unspecified
10.8
57.9
115
116
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
84.0
57.5
64
8
NF1AA
NOMESCO Finland
Hip X-ray examination
8.2
57.2
133
177
M01AC06
ATC
meloxicam; systemic, rectal
2.7
56.0
522
2568
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
55.6
53
*
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
55.6
53
*
WX320
NOMESCO Finland
Spinalanesthesy
3.5
53.2
285
957
M01AH01
ATC
celecoxib; oral (coxibs)
3.6
53.1
278
918
M20.1
ICD-10 Finland
Hallux valgus (acquired)
14.5
52.5
90
66
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
52.2
611
3379
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
15.3
50.7
85
59
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
+∞
49.3
47
*
A02BC02
ATC
pantoprazole; systemic
2.4
47.6
879
6018
M10.0
ICD-10 Finland
Idiopathic gout
18.1
47.2
74
43
ZXA00
NOMESCO Finland
Right side
2.8
46.7
376
1657
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
473.5
46.6
46
*
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
473.5
46.6
46
*
M13.8
ICD-10 Finland
Other specified arthritis
48.6
46.4
56
12
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
48.6
46.4
56
12
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
19.9
46.2
70
37
M01CB03
ATC
auranofin; oral
+∞
46.1
44
*
ZXA05
NOMESCO Finland
Left side
2.8
45.6
355
1529
M45
ICD-10 Finland
Ankylosing spondylitis
13.4
45.3
80
63
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
32.4
44.9
59
19
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
452.1
44.5
44
*
M01AE02
ATC
naproxen; oral, rectal
2.3
43.9
757
4921
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
6.1
43.4
125
224
ZX140
NOMESCO Finland
Intra articular
441.3
43.4
43
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
34.3
43.2
56
17
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
42.9
41
*
N02BE01
ATC
paracetamol; systemic, rectal
2.7
42.6
1115
8832
M04AA01
ATC
allopurinol; systemic
3.9
42.6
191
547
NG1DA
NOMESCO Finland
X-ray of knees
63.5
42.5
49
8
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.4
42.3
134
270
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
221.9
42.1
43
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
42.1
469
2451
M07.3
ICD-10 Finland
Other psoriatic arthropathies
419.9
41.3
41
*
M79.6
ICD-10 Finland
Pain in limb
2.4
40.3
458
2405
M01AH02
ATC
rofecoxib; oral
3.6
40.2
200
623
212
Kela drug reimbursment
Gout
+∞
39.8
38
*
L04AX01
ATC
azathioprine; systemic
6.6
39.5
106
173
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
24.3
39.5
56
24
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
205.9
39.0
40
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
17.0
38.9
62
38
L04AB06
ATC
golimumab; parenteral
58.1
38.5
45
8
M35.3
ICD-10 Finland
Polymyalgia rheumatica
7.5
37.9
92
130
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
+∞
37.7
36
*
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
+∞
37.7
36
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.0
37.1
160
440
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
46.5
37.1
45
10
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
35.3
298
1321
N03AX16
ATC
pregabalin; oral
2.5
35.0
318
1467
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
80.4
35.0
39
5
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
11.5
35.0
66
60
J01DB01
ATC
cefalexin; oral
2.3
35.0
1071
8552
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
34.8
518
3040
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
34.8
177
559
71493
ICD-8 Finland
Other specified forms of arthritis, Polyarthritis chronica seronegativa
+∞
34.5
33
*
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
34.5
33
*
Z3226
NOMESCO Finland
Physiotherapist
2.7
34.5
270
1144
B01AB05
ATC
enoxaparin; parenteral
2.4
34.5
363
1810
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
345.5
34.1
34
*
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
78.3
34.0
38
5
71107
ICD-8 Finland
Acute nonpyogenic arthritis, Loco multiplici
+∞
33.5
32
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
32.8
230
909
M09AX01
ATC
hyaluronic acid; parenteral
10.3
32.1
64
65
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
17.9
32.0
50
29
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
89.8
31.9
35
*
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
+∞
31.4
30
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
31.2
485
2864
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.6
30.9
93
176
R4110
NOMESCO Finland
Physiotherapy
2.3
30.5
361
1887
L04AA17
ATC
[U] adalimumab; parenteral
+∞
30.3
29
*
M01AX05
ATC
glucosamine; oral
2.9
30.3
205
788
L15
ICPC
Knee symptom/complaint
2.7
30.2
229
945
J01FF01
ATC
clindamycin; systemic
2.2
29.8
355
1857
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
8.2
29.6
67
85
M01AX17
ATC
nimesulide; oral
2.3
29.2
312
1548
R4120
NOMESCO Finland
Occupational therapy
4.1
29.2
118
305
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.8
29.1
68
91
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
41.1
29.1
36
9
WX111
NOMESCO Finland
Local infiltration anesthesia
298.1
28.9
29
*
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
12.0
28.3
52
45
L04AA01
ATC
[U] ciclosporin; systemic
16.6
28.2
45
28
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.0
27.9
180
669
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
4.3
27.6
108
270
L90
ICPC
Osteoarthrosis of knee
7.5
27.5
66
92
M05BA04
ATC
alendronic acid; oral
3.4
27.4
142
452
XX9XE
NOMESCO Finland
Other ultrasound examination
30.8
27.3
36
12
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.7
27.1
95
213
M19.2
ICD-10 Finland
Other secondary arthrosis
276.3
26.8
27
*
L04AA11
ATC
[U] etanercept; parenteral
276.3
26.8
27
*
M06
ICD-10 Finland
Other rheumatoid arthritis
142.8
26.7
28
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
26.6
469
2867
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.9
26.5
114
311
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.5
26.2
132
411
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
26.1
25
*
SPAT1202
SPAT
Intra-articular injection
8.1
25.9
59
76
A02BC03
ATC
lansoprazole; oral
2.1
25.9
373
2100
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
265.4
25.8
26
*
WZA10
NOMESCO Finland
Long statement of health and health related matters
13.3
25.8
45
35
ZX120
NOMESCO Finland
Intravenous
2.9
25.7
166
617
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
137.6
25.7
27
*
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
29.0
25.4
34
12
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
14.3
25.4
43
31
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
25.4
500
3172
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
12.2
25.3
46
39
N03AX12
ATC
gabapentin; oral
2.7
25.2
191
783
NDG30
NOMESCO Finland
Fusion of wrist, total
+∞
25.1
24
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
24.9
363
2050
M17.5
ICD-10 Finland
Other secondary gonarthrosis
71.3
24.9
28
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
13.4
24.8
43
33
H02AB04
ATC
methylprednisolone; systemic
2.6
24.6
201
858
M01AB55
ATC
diclofenac, combinations; oral
3.9
24.5
104
281
B01AX06
ATC
[U] rivaroxaban; oral
57.1
24.1
28
5
L20
ICPC
Joint symptom/complaint NOS
6.1
24.0
66
112
M01AB05
ATC
diclofenac; systemic, rectal
1.8
23.8
809
6139
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
23.5
336
1871
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
8.4
23.5
52
64
UJF32
NOMESCO Finland
Coloscopy
2.1
23.4
330
1830
M02AA07
ATC
piroxicam; topical
1.9
23.3
439
2720
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
55.0
23.1
27
5
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
+∞
23.0
22
*
M01AE01
ATC
ibuprofen; systemic, rectal
2.1
22.7
1128
9700
M20.2
ICD-10 Finland
Hallux rigidus
122.1
22.6
24
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
22.3
288
1536
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
22.0
147
554
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
+∞
21.9
21
*
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
+∞
21.9
21
*
1220
FHL
Arthroscopy
7.7
21.5
50
67
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.6
21.3
98
284
Z2221
NOMESCO Finland
Medical doctor
1.9
20.9
382
2325
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
14.3
20.9
35
25
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
+∞
20.9
20
*
C03CA01
ATC
furosemide; systemic
2.0
20.9
337
1958
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
213.1
20.6
21
*
M02.8
ICD-10 Finland
Other reactive arthropathies
111.7
20.6
22
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
18.6
20.5
31
17
ZXE00
NOMESCO Finland
One hour or less
1.8
20.4
495
3309
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
14.5
20.4
34
24
M22.4
ICD-10 Finland
Chondromalacia patellae
58.4
19.9
23
*
NDL52
NOMESCO Finland
Tenosynovectomy of hand
58.4
19.9
23
*
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
+∞
19.8
19
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
19.5
491
3313
SPAT1153
SPAT
Removal of sutures
1.9
19.4
370
2273
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
5.2
19.1
60
120
NF1DA
NOMESCO Finland
X-ray of hips
14.2
19.1
32
23
S18
ICPC
Laceration/cut
1.8
18.8
467
3124
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.4
18.8
69
163
M19.9
ICD-10 Finland
Arthrosis, unspecified
7.5
18.8
44
60
L13
ICPC
Hip symptom/complaint
2.5
18.8
160
694
J01MA02
ATC
ciprofloxacin; systemic
1.8
18.8
464
3103
ACC51
NOMESCO Finland
Release of median nerve
3.2
18.7
100
325
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
39.0
18.6
23
6
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
16.4
18.4
29
18
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
18.2
223
1151
M23.8
ICD-10 Finland
Other internal derangements of knee
9.5
18.2
37
40
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
18.1
136
552
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
33.4
18.0
23
7
L08
ICPC
Shoulder symptom/complaint
2.1
17.8
222
1157
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
17.8
148
633
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
17.7
17
*
L04AA24
ATC
abatacept; parenteral
+∞
17.7
17
*
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
17.7
17
*
R50.9
ICD-10 Finland
Fever, unspecified
2.3
17.6
178
841
M54.5
ICD-10 Finland
Low back pain
1.8
17.5
377
2401
1221
FHL
Arthroscopy and meniscus surgery
13.3
17.5
30
23
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
17.4
193
954
J01DA01
ATC
[U] cefalexin; systemic
1.7
17.4
766
5999
B01AF01
ATC
rivaroxaban; oral
3.0
17.3
105
373
M01AB01
ATC
indometacin; systemic, rectal
3.1
17.3
99
338
9271
FHL
Hallux surgery
42.6
17.3
21
5
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
17.3
209
1073
M01AX01
ATC
nabumetone; oral
4.4
17.2
63
149
WX002
NOMESCO Finland
Sedation and analgesia
2.0
17.1
233
1258
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.1
17.0
97
330
L17
ICPC
Foot/toe symptom/complaint
1.9
16.9
275
1586
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.5
16.7
60
139
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
+∞
16.7
16
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.9
16.7
70
188
M15.8
ICD-10 Finland
Other polyarthrosis
15.3
16.7
27
18
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
16.6
337
2100
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
27.9
16.5
22
8
A02BC01
ATC
omeprazole; systemic
1.8
16.5
330
2045
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
40.6
16.3
20
5
RT272
NOMESCO Finland
NA
40.6
16.3
20
5
M03BX02
ATC
tizanidine; oral
1.6
16.3
725
5653
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
10.5
16.2
31
30
M70.6
ICD-10 Finland
Trochanteric bursitis
2.5
16.2
134
574
N06AA09
ATC
amitriptyline; systemic
2.6
16.1
127
528
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
17.0
16.1
25
15
E0000UV
ATC
NA
1.7
16.0
478
3339
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
15.9
283
1683
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
15.8
92
318
M47.9
ICD-10 Finland
Spondylosis, unspecified
5.3
15.8
48
93
S83.2
ICD-10 Finland
Tear of meniscus, current
3.7
15.8
69
192
M19.8
ICD-10 Finland
Other specified arthrosis
6.4
15.7
41
66
L89
ICPC
Osteoarthrosis of hip
13.1
15.7
27
21
291
Kela drug reimbursment
Tofacitinib
+∞
15.6
15
*
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
15.6
15
*
7168A
ICD-9 Finland
Other and unspecified arthropathies, Other specified arthropathy
+∞
15.6
15
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.5
15.6
56
130
M25.4
ICD-10 Finland
Effusion of joint
13.9
15.5
26
19
NG2AA
NOMESCO Finland
Patella X-ray examination
13.9
15.5
26
19
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
161.7
15.5
16
*
NHG82
NOMESCO Finland
Fusion of other tarsal joint
161.7
15.5
16
*
R06.0
ICD-10 Finland
Dyspnoea
1.8
15.3
283
1702
N02AA05
ATC
oxycodone; systemic
2.2
15.3
167
816
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.1
15.2
41
69
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
23.7
15.1
21
9
J01AA02
ATC
doxycycline; systemic
1.7
15.1
958
8118
WZA90
NOMESCO Finland
Other doctors statement
1.9
14.8
251
1465
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
14.7
335
2154
9256
FHL
Synovectomy (knee 9311)
+∞
14.6
14
*
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
+∞
14.6
14
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
14.6
14
*
M16.7
ICD-10 Finland
Other secondary coxarthrosis
81.0
14.6
16
*
ZXD05
NOMESCO Finland
Urgent procedure
1.7
14.5
377
2516
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
151.5
14.5
15
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
15.6
14.4
23
15
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
14.4
165
824
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
27.5
14.3
19
7
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
14.1
102
403
1223
FHL
Arthroscopy and articular cartilage surgery
42.9
14.1
17
*
L04AB05
ATC
certolizumab pegol; parenteral
42.9
14.1
17
*
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
17.7
13.8
21
12
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
53.9
13.8
16
*
J01FA06
ATC
roxithromycin; oral
1.6
13.7
479
3456
M48.0
ICD-10 Finland
Spinal stenosis
2.4
13.7
124
556
ND1AA
NOMESCO Finland
Wrist X-ray examination
3.0
13.6
80
280
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.8
13.6
45
97
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
+∞
13.6
13
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
+∞
13.6
13
*
NH3AE
NOMESCO Finland
Feet ultrasound examination
+∞
13.6
13
*
D07AC01
ATC
betamethasone; topical
1.7
13.5
390
2670
NHG22
NOMESCO Finland
Fusion of subtalar joint
141.3
13.5
14
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
13.4
207
1163
Z3231
NOMESCO Finland
Registered nurse
1.7
13.4
332
2177
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
8.2
13.3
29
36
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
13.3
128
590
K07.60
ICD-10 Finland
Snapping jaw
3.4
13.2
64
195
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
13.2
168
878
NH1AD
NOMESCO Finland
Ankle and foot CT
5.9
13.2
36
62
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
40.5
13.2
16
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
13.1
125
574
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
13.1
66
207
A02BC05
ATC
esomeprazole; systemic
1.6
12.9
451
3239
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
7.0
12.9
31
45
L12
ICPC
Hand/finger symptom/complaint
2.1
12.9
159
819
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.3
12.7
46
109
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
70.5
12.6
14
*
H02AB08
ATC
triamcinolone; systemic
70.5
12.6
14
*
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
70.5
12.6
14
*
E000001
ATC
NA
1.8
12.6
242
1464
M02.3
ICD-10 Finland
Reiter disease
+∞
12.5
12
*
NHG20
NOMESCO Finland
Fusion of talocrural joint
131.1
12.4
13
*
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
131.1
12.4
13
*
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
131.1
12.4
13
*
ND1AE
NOMESCO Finland
Wrist ultrasound examination
37.9
12.2
15
*
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
37.9
12.2
15
*
L03
ICPC
Low back symptom/complaint
1.7
12.1
262
1645
M35.7
ICD-10 Finland
Hypermobility syndrome
7.8
12.1
27
35
A46
ICD-10 Finland
Erysipelas
2.0
12.1
155
810
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
26.9
12.1
16
6
ZXD20
NOMESCO Finland
Day surgery
2.0
12.0
155
814
N06AX21
ATC
duloxetine; oral
2.2
12.0
120
564
R03AC02
ATC
salbutamol; inhalant
1.5
11.9
596
4635
1222
FHL
Arthroscopy and synovial surgery
47.1
11.9
14
*
L04AA29
ATC
tofacitinib; oral
47.1
11.9
14
*
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
11.8
11.8
21
18
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.3
11.7
35
68
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
16.6
11.7
18
11
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
11.7
259
1638
M15
ICD-10 Finland
Polyarthrosis
4.0
11.6
46
119
RT271
NOMESCO Finland
NA
65.5
11.6
13
*
L04AC10
ATC
secukinumab; parenteral
65.5
11.6
13
*
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
65.5
11.6
13
*
NDG76
NOMESCO Finland
Fusion of DIP joint
23.1
11.6
16
7
SPAT1229
SPAT
Assessment of need for aid
2.5
11.5
90
373
ZXX09
NOMESCO Finland
Extent of procedure, more than 8 units
+∞
11.5
11
*
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
11.5
11
*
L04AC07
ATC
tocilizumab; parenteral
+∞
11.5
11
*
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
11.5
11
*
NHF15
NOMESCO Finland
Synovectomy of ankle, arthroscopic
121.0
11.4
12
*
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
121.0
11.4
12
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
11.4
48
131
B01AB04
ATC
dalteparin; parenteral
3.0
11.4
66
229
J01CA04
ATC
amoxicillin; systemic
1.6
11.4
968
8433
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
11.4
286
1872
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
6.1
11.4
30
50
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
8.4
11.3
24
29
D05AX52
ATC
calcipotriol, combinations; topical
2.9
11.3
70
254
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.2
11.3
42
103
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
7.3
11.2
26
36
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
3.0
11.2
65
226
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
11.1
114
542
R60.0
ICD-10 Finland
Localized oedema
2.2
11.1
116
556
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
11.0
63
217
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
10.9
398
2866
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
10.8
643
5158
R06AE07
ATC
cetirizine; oral
1.5
10.7
500
3800
P01BA01
ATC
chloroquine; systemic
18.0
10.7
16
9
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
13.0
10.7
18
14
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
10.7
79
320
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
60.5
10.6
12
*
L04AD01
ATC
ciclosporin; systemic
5.4
10.6
31
59
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
10.5
142
758
M12.3
ICD-10 Finland
Palindromic rheumatism
+∞
10.4
10
*
L01CB
ATC
Podophyllotoxin derivatives
+∞
10.4
10
*
71490
ICD-8 Finland
Other specified forms of arthritis, Arthritis postinfectiosa NUD
+∞
10.4
10
*
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
+∞
10.4
10
*
NGF10
NOMESCO Finland
Total synovectomy of knee, open
+∞
10.4
10
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
10.4
314
2153
B01AA03
ATC
warfarin; systemic
1.8
10.3
202
1226
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
10.3
152
839
X58
ICD-10 Finland
Exposure to other specified factors
2.0
10.3
136
718
R51.80
ICD-10 Finland
Headache
1.9
10.3
157
879
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
10.2
188
1120
M01AB08
ATC
etodolac; oral
2.4
10.2
82
348
D07AC13
ATC
mometasone; topical
1.6
10.1
330
2306
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
10.1
347
2456
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
11.4
10.1
18
16
L28
ICPC
Limited function/disability (L)
1.9
10.0
155
870
3005
Kela drug reimbursment
Tofacitinib
40.4
10.0
12
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
9.9
86
378
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.9
9.9
31
64
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
9.8
189
1140
ZXA10
NOMESCO Finland
Bilateral
1.7
9.8
197
1203
M01AE52
ATC
naproxen and esomeprazole; oral
4.0
9.7
38
98
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.6
9.7
69
272
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.8
9.7
40
108
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
9.7
79
336
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
5.4
9.7
28
53
NF1AT
NOMESCO Finland
Puncture of hip joint with ultrasound guidance
55.4
9.7
11
*
9522
FHL
Synovectomy
55.4
9.7
11
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.6
9.6
71
286
M25.9
ICD-10 Finland
Joint disorder, unspecified
11.5
9.6
17
15
L16
ICPC
Ankle symptom/complaint
2.1
9.5
108
538
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.8
9.5
59
215
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
9.4
93
435
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
9.4
465
3556
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
100.7
9.4
10
*
NDG74
NOMESCO Finland
Fusion of first IP joint
100.7
9.4
10
*
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
100.7
9.4
10
*
RT171
NOMESCO Finland
NA
30.2
9.4
12
*
RT350
NOMESCO Finland
NA
30.2
9.4
12
*
M02.1
ICD-10 Finland
Postdysenteric arthropathy
+∞
9.4
9
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
9.3
136
745
N02AJ13
ATC
tramadol and paracetamol; systemic
5.8
9.2
25
44
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
9.2
98
473
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
9.2
307
2150
S97
ICPC
Chronic ulcer skin
2.7
9.2
62
238
M01AC01
ATC
piroxicam; systemic, rectal
1.9
9.2
146
827
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
9.1
115
597
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
9.1
80
354
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.4
9.1
43
131
WX110
NOMESCO Finland
Local anesthesy
1.4
9.1
789
6718
J01FA10
ATC
azithromycin; systemic
1.4
9.0
657
5403
M43.1
ICD-10 Finland
Spondylolisthesis
3.3
9.0
44
137
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.0
228
1489
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
9.0
42
127
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
9.0
220
1422
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
8.9
180
1102
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
5.5
8.9
25
46
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
24.2
8.9
12
5
R4180
NOMESCO Finland
Podiatric therapy
8.0
8.9
19
24
G56.2
ICD-10 Finland
Lesion of ulnar nerve
3.4
8.8
41
123
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
8.8
98
484
J01MA12
ATC
levofloxacin; systemic
1.7
8.8
199
1258
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
8.7
8.8
18
21
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
8.8
229
1505
WX204
NOMESCO Finland
Axillary plexus blockaced
3.5
8.8
39
113
M35.1
ICD-10 Finland
Other overlap syndromes
10.8
8.8
16
15
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
8.8
100
499
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.6
8.8
38
108
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
3.7
8.8
36
98
M15.4
ICD-10 Finland
Erosive (osteo)arthrosis
50.3
8.7
10
*
A02BA02
ATC
ranitidine; systemic
1.6
8.6
217
1410
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
8.6
173
1058
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
16.4
8.6
13
8
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
16.4
8.6
13
8
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
8.5
209
1352
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
9.0
8.5
17
19
M02AA10
ATC
ketoprofen; topical
1.8
8.5
158
942
ZXX06
NOMESCO Finland
Extent of procedure, 6 units
27.7
8.5
11
*
NBF15
NOMESCO Finland
Humeroscapular synovectomy, arthroscopic
27.7
8.5
11
*
71599
ICD-8 Finland
Arthritis, unspecified
20.2
8.5
12
6
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
8.5
718
6045
M05BA07
ATC
risedronic acid; oral
3.2
8.4
43
139
M11.2
ICD-10 Finland
Other chondrocalcinosis
90.6
8.4
9
*
4AC07
NOMESCO Finland
NA
90.6
8.4
9
*
NDF10
NOMESCO Finland
Synovectomy of wrist
90.6
8.4
9
*
Z50.1
ICD-10 Finland
Other physical therapy
2.6
8.4
59
234
ZZH31
NOMESCO Finland
Bone allograft, small pieces
12.8
8.4
14
11
ZX100
NOMESCO Finland
Oral
5.1
8.3
25
50
7354A
ICD-9 Finland
Acquired deformities of toe, Other hammer toe (acquired)
+∞
8.3
8
*
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
+∞
8.3
8
*
M23.4
ICD-10 Finland
Loose body in knee
+∞
8.3
8
*
3006
Kela drug reimbursment
Baricitinib
+∞
8.3
8
*
7174A
ICD-9 Finland
Internal derangement of knee, Derangement of lateral meniscus
+∞
8.3
8
*
M01CC01
ATC
penicillamine; oral
+∞
8.3
8
*
L04AA37
ATC
baricitinib; oral
+∞
8.3
8
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.6
8.3
17
20
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.0
8.3
45
152
H20.1
ICD-10 Finland
Chronic iridocyclitis
5.9
8.3
22
38
1225
FHL
Arthroscopy and other therapeutic procedure
10.8
8.3
15
14
C07AB07
ATC
bisoprolol; oral
1.4
8.3
507
4018
J01CF02
ATC
cloxacillin; systemic
3.7
8.3
34
93
SPAT1310
SPAT
Counselling related to known health issue
1.5
8.2
349
2571
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
6.5
8.2
20
31
SPAT1301
SPAT
No procedures
1.5
8.2
341
2504
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
5.4
8.2
23
43
N06AX11
ATC
mirtazapine; oral
1.5
8.1
343
2521
L11
ICPC
Wrist symptom/complaint
2.1
8.1
86
416
RF210
NOMESCO Finland
NA
3.6
8.1
35
100
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
33.5
8.1
10
*
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
17.3
8.1
12
7
C08CA05
ATC
nifedipine; systemic
2.3
8.1
71
316
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.8
8.0
48
173
M81.4
ICD-10 Finland
Drug-induced osteoporosis
22.2
8.0
11
5
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.0
605
4970
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
4.2
8.0
29
71
WZC30
NOMESCO Finland
Teaching
1.8
8.0
148
879
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.6
8.0
55
215
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.9
288
2049
Z2446
NOMESCO Finland
Social worker
2.2
7.9
78
366
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
7.9
132
759
SPAT1254
SPAT
Administration of medicine
1.7
7.9
154
929
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
3.0
7.9
45
155
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
7.9
119
660
N05CF01
ATC
zopiclone; oral
1.5
7.8
346
2567
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.8
163
1008
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.8
459
3601
WX200
NOMESCO Finland
Interscalenous plexus blockade
5.1
7.7
23
46
ND2CG
NOMESCO Finland
Extensive MRI of hand
45.2
7.7
9
*
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
45.2
7.7
9
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.2
7.7
38
121
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.2
7.7
38
121
K02.1
ICD-10 Finland
Caries of dentine
1.4
7.7
626
5202
N02AC04
ATC
dextropropoxyphene; oral
3.0
7.7
41
138
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.4
7.7
63
272
D05AX02
ATC
calcipotriol; topical
3.0
7.6
42
144
M79.7
ICD-10 Finland
Fibromyalgia
3.5
7.6
34
100
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
7.6
54
216
A01
ICPC
Pain general/multiple sites
2.2
7.6
76
360
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
18.5
7.6
11
6
SPAT1255
SPAT
Intravenous administration of medicine
2.2
7.6
71
327
D07XC01
ATC
betamethasone, combinations; topical
1.8
7.6
122
695
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.3
7.5
36
112
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.5
436
3407
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.5
7.5
56
230
J01MA14
ATC
moxifloxacin; systemic
2.0
7.5
97
511
J01FA09
ATC
clarithromycin; systemic
1.5
7.5
343
2561
J02AC01
ATC
fluconazole; systemic
1.4
7.5
432
3369
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
7.4
59
251
A28
ICPC
Limited function/disability NOS
1.7
7.4
143
860
ND2AE
NOMESCO Finland
Hand and fingers ultrasound examination
80.5
7.4
8
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.4
296
2147
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.2
7.4
72
338
L01
ICPC
Neck symptom/complaint
1.7
7.4
141
849
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
+∞
7.3
7
*
7166A
ICD-9 Finland
Other and unspecified arthropathies, Unspecified monoarthritis
+∞
7.3
7
*
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
7.3
7
*
M06.1
ICD-10 Finland
Adult-onset Still disease
+∞
7.3
7
*
293
Kela drug reimbursment
Baricitinib
+∞
7.3
7
*
M25.2
ICD-10 Finland
Flail joint
+∞
7.3
7
*
M00.0
ICD-10 Finland
Staphylococcal arthritis and polyarthritis
+∞
7.3
7
*
NFB99
NOMESCO Finland
Other primary prosthetic replacement of hip joint
+∞
7.3
7
*
NCF10
NOMESCO Finland
Synovectomy of elbow joint, open
+∞
7.3
7
*
9279
FHL
Other measure in this category
+∞
7.3
7
*
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
+∞
7.3
7
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
7.3
582
4803
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.3
525
4258
Z71.8
ICD-10 Finland
Other specified counselling
1.5
7.3
248
1739
M24.2
ICD-10 Finland
Disorder of ligament
15.8
7.2
11
7
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.5
7.2
20
37
M76.9
ICD-10 Finland
Enthesopathy of lower limb, unspecified
5.8
7.2
19
33
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
7.2
432
3389
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.2
558
4580
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
7.2
54
223
NDG20
NOMESCO Finland
Fusion of wrist, partial
20.1
7.1
10
5
4AA12
NOMESCO Finland
NA
20.1
7.1
10
5
9255
FHL
Joint auger removal
20.1
7.1
10
5
R05
ICD-10 Finland
Cough
1.6
7.1
206
1386
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
7.1
358
2719
R01AD09
ATC
mometasone; nasal
1.4
7.1
476
3811
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
7.1
153
956
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.4
7.0
32
96
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.7
7.0
45
168
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
7.0
72
346
J04AB02
ATC
rifampicin; systemic
7.0
7.0
16
23
R02
ICPC
Shortness of breath/dyspnoea
1.8
7.0
121
707
R5599
NOMESCO Finland
Other rehabilitation service
3.4
6.9
31
92
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.5
6.9
19
35
AN1
HP
Coronary angiography
1.8
6.9
118
684
J01DA06
ATC
[U] cefuroxime; systemic
1.7
6.9
159
1009
C08CA13
ATC
lercanidipine; oral
1.7
6.9
135
820
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.9
406
3170
D07AD01
ATC
clobetasol; topical
1.6
6.8
160
1018
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.5
6.8
49
198
M10
ICD-10 Finland
Gout
2.9
6.8
40
143
9243
FHL
Plastic of the patella and its tendons
11.0
6.8
12
11
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
11.0
6.8
12
11
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
6.8
158
1004
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
6.8
60
269
M15.3
ICD-10 Finland
Secondary multiple arthrosis
40.2
6.8
8
*
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
40.2
6.8
8
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.1
6.8
68
325
205
Kela drug reimbursment
Chronic hypertension
1.5
6.7
280
2044
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
6.7
259
1861
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.1
6.7
24
59
SPAT1263
SPAT
Sampling
1.4
6.7
449
3583
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
6.7
89
476
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
3.3
6.7
31
95
M01AB16
ATC
aceclofenac; oral
3.0
6.7
36
123
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
6.6
219
1521
D07AA02
ATC
hydrocortisone; topical
1.7
6.6
147
923
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
4.2
6.6
23
55
R42
ICD-10 Finland
Dizziness and giddiness
1.5
6.6
213
1472
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
12.3
6.6
11
9
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
6.6
82
428
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.6
127
766
M19
ICD-10 Finland
Other arthrosis
4.8
6.5
20
42
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
10.1
6.5
12
12
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.2
6.5
31
97
L18
ICPC
Muscle pain
2.6
6.5
43
166
L99
ICPC
Musculoskeletal disease other
4.2
6.5
23
56
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.2
6.5
32
103
M01AH03
ATC
valdecoxib; oral
2.2
6.5
60
274
M66.0
ICD-10 Finland
Rupture of popliteal cyst
6.2
6.5
16
26
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
6.5
58
263
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.5
213
1480
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.5
240
1711
NHB10
NOMESCO Finland
Primary partial prosthetic replacement of ankle joint
70.1
6.4
7
*
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
7.4
6.4
14
19
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
6.4
49
205
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.4
90
489
R2110
NOMESCO Finland
Giving the first information
2.0
6.4
80
417
SPAT1312
SPAT
General health counselling
1.4
6.4
343
2627
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
6.3
52
226
L04AA06
ATC
mycophenolic acid; systemic
3.9
6.3
24
63
M25.0
ICD-10 Finland
Haemarthrosis
18.1
6.3
9
5
M03.2*A04.6
ICD-10 Finland
Postinfectious arthropathy in enteritis due to Yersinia enterocolitica
+∞
6.3
6
*
TEG00
NOMESCO Finland
Punction of mandibular joint
+∞
6.3
6
*
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
6.3
6
*
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
+∞
6.3
6
*
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
+∞
6.3
6
*
ZXX08
NOMESCO Finland
Extent of procedure, 8 units
+∞
6.3
6
*
NDB60
NOMESCO Finland
Prosthetic replacement of MCP joint of finger
+∞
6.3
6
*
M16.6
ICD-10 Finland
Other secondary coxarthrosis, bilateral
+∞
6.3
6
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
4.3
6.2
21
49
M79.1
ICD-10 Finland
Myalgia
1.7
6.2
127
779
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
6.2
791
6956
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
6.2
186
1264
B01AE07
ATC
dabigatran etexilate; oral
2.6
6.1
41
160
RF220
NOMESCO Finland
NA
4.7
6.1
19
41
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
12.6
6.1
10
8
JN4BD
NOMESCO Finland
Extensive body CT
1.7
6.1
121
737
K07
ICPC
Swollen ankles/oedema
2.5
6.1
44
180
M23.3
ICD-10 Finland
Other meniscus derangements
8.6
6.1
12
14
SPAT1104
SPAT
Monitoring of emergency patient
2.0
6.0
69
348
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
6.0
141
898
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
3.6
6.0
25
71
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021788) Differential panel - Synovial fluid
177
31
64.98
319.58
1.8
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
240
57
50.35
307.65
2.3
1.1
e6/l
16799.7
13425.7
0.18
195
42
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
248
71
42.01
307.65
1.8
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
587
1249
7.26
286.75
1.5
1.1
u/ml
15.1
2.7
3.84
228
503
(3037522) Nuclear Ab [Titer] in Serum
531
1064
7.33
273.95
1.5
1.3
titre
364.3
494.9
1.42
129
198
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
599
1358
6.85
272.74
1.5
1.2
iu/ml
24.7
18.1
1.20
219
369
(3044941) Cell count panel - Synovial fluid
152
45
37.66
242.65
1.7
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
111
25
48.04
189.25
1.9
1.1
%
51.9
61.3
0.48
85
15
(3001604) Monocytes [#/volume] in Blood
1062
5127
5.11
175.27
13.0
5.1
e9/l
0.6
0.6
2.58
988
4367
(3006315) Basophils [#/volume] in Blood
1064
5147
5.12
175.05
13.1
5.1
e9/l
0.0
0.0
0.69
989
4391
(3019198) Lymphocytes [#/volume] in Blood
1070
5306
4.99
167.36
13.1
5.1
e9/l
2.1
1.9
0.26
1015
4607
(3013115) Eosinophils [#/volume] in Blood
1075
5359
5.00
166.70
13.3
5.3
e9/l
0.2
0.2
2.10
1022
4623
(3010144) Erythrocytes [#/volume] in Synovial fluid
101
27
40.16
164.96
1.9
1.0
e6/l
11117.8
27154.4
0.34
77
18
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
93
19
52.27
161.64
2.0
1.2
%
34.0
24.1
0.59
74
13
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
191
220
9.86
155.45
1.5
1.6
iu/ml
0.1
0.0
0.32
53
41
(3008898) HLA-B27 [Presence]
191
228
9.51
151.15
1.0
1.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
954
4696
4.07
141.58
13.4
5.2
%
0.7
0.7
1.57
930
4376
(42870588) Differential panel, method unspecified - Blood
783
3417
3.84
138.31
11.7
5.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1116
6210
4.58
136.64
16.2
8.8
e9/l
4.2
4.1
0.39
1037
5388
(3019069) Monocytes/100 leukocytes in Blood
962
4867
3.96
134.56
13.8
5.5
%
8.8
8.6
1.95
938
4551
(3006504) Eosinophils/100 leukocytes in Blood
958
4844
3.94
133.86
13.5
5.3
%
2.7
2.8
1.49
934
4511
(3018010) Neutrophils/100 leukocytes in Blood
963
4953
3.87
129.55
13.1
5.1
%
58.3
57.2
2.46
940
4631
(3002030) Lymphocytes/100 leukocytes in Blood
965
5041
3.79
125.10
13.5
5.3
%
27.1
28.0
2.00
941
4687
(3026493) Urate [Moles/volume] in Serum or Plasma
615
2447
3.65
121.74
3.3
2.4
umol/l
4108.9
7678.4
1.27
550
2135
(3013707) Erythrocyte sedimentation rate by Westergren method
1223
7768
4.87
112.79
10.3
3.1
mm/h
14.8
11.6
9.06
1191
7094
(3015171) Extractable nuclear Ab [Units/volume] in Serum
178
302
6.59
102.60
1.2
1.2
u/ml
0.7
0.6
0.05
24
21
(3024263) Appearance of Synovial fluid
58
17
35.51
91.83
3.6
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
517
2288
2.97
79.26
7.7
4.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1197
8398
3.56
74.69
12.4
7.1
u/l
76.9
78.7
0.59
1171
7901
(3009445) Proteinase 3 Ab [Units/volume] in Serum
177
398
4.93
74.55
1.8
1.3
u/ml
10.6
8.6
—
13
7
(3035350) Ketones [Presence] in Urine by Test strip
877
5218
2.75
74.33
5.8
3.3
estimate
0.0
0.0
0.00
172
943
(3018095) Leukocytes [#/volume] in Urine
699
3731
2.70
73.47
4.9
3.3
e6/l
51.8
132.4
2.52
499
2591
(3009261) Glucose [Presence] in Urine by Test strip
881
5289
2.72
72.73
5.9
3.3
estimate
0.0
0.0
0.80
180
920
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
135
244
6.00
72.45
1.9
1.6
g/l
0.2
0.2
0.30
129
235
(3042936) Bacteria identified in Isolate by Culture
351
1311
3.22
71.61
2.6
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
870
5230
2.68
70.96
7.7
4.5
estimate
0.0
0.0
0.50
184
952
(3037467) Urinalysis macro (dipstick) panel - Urine
1099
7457
3.02
70.25
7.0
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
503
2375
2.72
66.10
5.6
3.3
—
—
—
0
0
(3015736) pH of Urine
717
4049
2.54
64.66
5.3
3.1
—
5.9
—
0
6
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
759
4402
2.54
64.63
2.7
2.1
nmol/l
76.6
76.6
0.00
714
3943
(3021589) Normoblasts [#/volume] in Blood
805
4809
2.53
64.15
17.5
8.5
e9/l
0.0
0.0
0.55
711
3872
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
142
303
5.09
63.36
1.7
1.5
titre
336.0
125.0
—
10
8
(40758558) Short blood count panel - Blood
543
2710
2.61
63.27
11.2
6.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
230
725
3.59
60.93
2.7
2.8
g/l
10.6
10.2
0.43
223
662
(3000850) Epithelial cells [#/volume] in Urine
462
2166
2.67
60.74
3.1
2.4
e6/l
4.9
6.7
1.92
412
1876
(3036071) Salmonella sp Ab [Titer] in Serum
43
18
24.60
60.37
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
196
576
3.78
57.50
1.7
2.0
g/l
1.3
1.4
0.36
188
529
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
662
3783
2.39
55.80
4.8
2.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
536
2822
2.43
53.96
5.3
4.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
583
3191
2.39
53.72
4.0
2.9
e6/l
21.1
66.8
2.85
467
2407
(3018418) pH of Serum or Plasma
572
3114
2.39
53.25
4.5
3.9
ph
7.4
7.4
1.66
101
596
(36304419) Bacteria [Presence] in Urine
535
2831
2.42
53.08
3.7
2.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
233
805
3.26
52.99
5.4
4.2
%
0.9
0.9
0.04
75
233
(3030467) Casts [#/volume] in Urine by Automated count
542
2887
2.41
52.96
3.8
2.9
e6/l
0.3
0.6
4.85
430
2143
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
829
5327
2.32
51.84
8.0
6.6
mmol/l
1.2
1.2
0.39
718
4482
(3021440) Promyelocytes/100 leukocytes in Blood
222
761
3.27
51.05
5.4
4.3
%
0.1
0.1
1.04
68
216
(3021879) Hepatitis B virus core Ab [Presence] in Serum
205
686
3.32
48.94
1.3
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
211
719
3.27
48.90
5.6
4.2
%
0.1
0.1
0.23
59
183
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
197
650
3.35
48.08
2.2
2.3
au/ml
15.3
22.1
—
8
39
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
757
4820
2.21
46.59
7.4
5.9
mmol/l
1.2
1.2
0.05
722
4346
(3017143) Hepatitis C virus Ab [Presence] in Serum
270
1095
2.81
45.81
1.5
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
80
135
6.22
45.79
1.8
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
84
150
5.89
45.39
1.4
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
209
743
3.12
44.93
4.8
4.1
%
0.3
0.7
3.33
52
168
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
107
240
4.74
44.75
1.9
1.7
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
34
17
20.46
44.31
1.7
2.3
mg/l
10.1
7.3
0.96
28
12
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
180
590
3.34
44.26
1.2
1.3
au/ml
34.9
36.8
—
7
26
(3004588) Protein electrophoresis panel - Serum or Plasma
187
633
3.25
43.61
2.3
2.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
94
204
4.86
40.86
1.4
1.2
u/ml
10.8
2.6
0.55
19
22
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
81
155
5.48
40.63
1.3
1.2
u/ml
1.0
1.7
—
7
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
94
205
4.84
40.62
1.4
1.2
u/ml
10.4
8.8
0.09
23
34
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
534
3090
2.16
40.40
2.3
2.0
u/l
201.8
260.7
0.47
497
2906
(3020630) Protein [Mass/volume] in Serum or Plasma
210
801
2.90
39.62
2.4
2.9
g/l
65.6
66.1
0.38
194
731
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
353
1740
2.36
39.31
3.0
2.6
e6/l
0.8
1.2
2.26
218
962
(3007164) IgA [Mass/volume] in Serum or Plasma
395
2047
2.28
39.09
1.6
1.5
g/l
2.7
2.4
1.78
275
1265
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
295
1345
2.50
39.02
2.6
2.5
%
21.7
23.5
1.33
266
1145
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
142
433
3.53
38.98
1.9
2.1
u/l
38.1
38.7
0.14
125
384
(3004789) Transferrin [Mass/volume] in Serum or Plasma
303
1436
2.41
36.61
2.6
2.4
g/l
2.2
2.3
1.49
288
1329
(3022948) Iron [Moles/volume] in Serum or Plasma
322
1574
2.35
36.23
2.6
2.4
umol/l
12.2
13.7
3.19
310
1444
(3024561) Albumin [Mass/volume] in Serum or Plasma
704
4666
2.00
35.57
5.8
4.8
g/l
34.5
35.6
4.93
674
4331
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
46
59
8.02
33.75
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
46
59
8.02
33.75
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
46
59
8.02
33.75
1.4
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
98
261
3.96
32.69
2.0
2.2
mg/l
11.2
11.0
0.05
88
235
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
45
59
7.84
32.41
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
45
59
7.84
32.41
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
45
59
7.84
32.41
1.4
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
301
1493
2.29
32.38
1.5
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
451
2630
2.04
31.94
2.7
2.0
mg/l
3.1
2.9
0.92
405
2207
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
77
174
4.62
31.83
5.4
3.5
%
57.8
57.0
0.20
77
174
(3030905) Polymorphonuclear cells [#/volume] in Blood
75
166
4.71
31.80
4.6
3.0
e9/l
4.4
4.0
0.65
75
166
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1318
11281
3.05
31.71
28.0
12.3
mg/l
22.5
25.9
3.69
1197
8602
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
255
1191
2.39
31.46
3.5
4.5
u/l
237.0
244.7
0.43
247
1127
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
97
264
3.87
31.38
2.0
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
469
2805
2.00
30.72
7.2
3.5
estimate
0.0
0.0
1.34
172
923
(3026782) Osmolality of Urine
377
2096
2.08
30.15
3.4
2.5
mosm/kgh2o
541.8
547.5
0.18
328
1769
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
620
4104
1.90
29.82
6.6
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
96
269
3.75
29.78
1.2
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
240
1120
2.37
29.54
3.2
2.5
%
1.8
1.7
0.82
228
988
(3007853) Bacteria identified in Skin by Aerobe culture
241
1147
2.32
28.27
2.2
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
395
2302
1.99
27.34
7.5
3.4
kg/l
1.0
1.0
0.84
52
341
(3031040) Bacteria [#/volume] in Urine by Automated count
936
7188
1.87
26.97
5.8
4.0
e6/l
706.3
2789.4
1.26
15
106
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
343
3.26
26.33
2.4
2.2
g/l
10.4
10.4
0.01
97
287
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
68
168
4.20
25.09
1.3
1.2
u/ml
33.2
41.4
—
5
14
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
110
375
3.09
25.03
2.6
2.2
g/l
7.9
7.2
2.65
88
274
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
375
3.06
24.42
2.6
2.2
g/l
3.9
3.7
0.59
87
259
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
109
375
3.06
24.42
2.6
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
182
818
2.40
24.14
6.0
3.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
169
737
2.47
23.94
1.8
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
121
447
2.86
23.87
1.6
1.8
g/l
1.7
1.5
1.31
107
383
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
307
1712
2.01
23.67
2.2
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
329
1889
1.96
23.29
1.8
1.7
nmol/l
1129.6
1150.5
0.17
274
1433
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
772
5746
1.74
23.08
6.6
6.6
umol/l
11.0
11.7
0.52
741
5460
(3023520) Reticulocytes [#/volume] in Blood
180
831
2.33
22.40
3.1
2.7
e9/l
72.3
69.5
0.39
134
635
(46235355) HIV 1 and 2 tests - Meaningful Use set
321
1851
1.95
22.33
1.6
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
596
4195
1.72
21.23
9.9
8.6
inr
1.2
1.2
0.48
175
1219
(3036481) Cortisol [Moles/volume] in Serum or Plasma
199
980
2.20
21.17
2.4
2.2
nmol/l
347.1
382.9
1.71
192
897
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
99
352
2.95
20.91
2.7
2.2
g/l
3.4
3.0
2.50
87
267
(3052851) Hemolysis interference index of Serum or Plasma
90
303
3.10
20.91
2.6
3.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
523
3567
1.73
20.76
4.1
3.3
u/l
30.7
34.9
1.05
503
3399
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
380
2362
1.83
20.75
1.2
1.3
u/ml
1.7
1.8
0.01
110
611
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
66
184
3.71
20.62
1.1
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
42
82
5.25
20.59
1.2
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
540
3731
1.72
20.36
3.1
3.6
mmol/l
2.3
2.4
0.48
480
3304
(3002385) Erythrocyte distribution width [Ratio]
1133
9577
1.87
20.31
30.5
15.5
%
14.0
13.6
13.73
1120
9335
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
289
1670
1.91
19.73
3.5
2.7
e6/l
2.7
2.6
0.05
156
891
(3001122) Ferritin [Mass/volume] in Serum or Plasma
646
4729
1.67
19.30
3.4
2.6
ug/l
160.2
131.5
1.36
611
4391
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
437
2884
1.74
19.21
3.5
3.1
ng/l
1488.6
1331.5
0.36
383
2462
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
602
4332
1.67
19.18
2.2
1.9
pmol/l
92.1
94.0
0.48
344
2240
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
658
4849
1.66
19.09
5.1
3.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
108
423
2.68
19.02
2.1
2.0
ug/l
1.8
1.4
0.26
98
380
(3004616) Nuclear Ab [Presence] in Serum
42
88
4.89
19.02
1.5
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
206
1071
2.08
18.96
8.0
7.9
%
95.7
95.6
0.08
195
1035
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
26
34
7.77
18.72
1.2
1.2
iu/ml
167.8
203.8
0.30
26
34
(3002173) Hemoglobin [Mass/volume] in Arterial blood
195
1001
2.10
18.54
8.3
8.3
g/l
118.3
122.3
1.93
186
964
(3014111) Lactate [Moles/volume] in Serum or Plasma
187
947
2.12
18.42
8.0
7.2
mmol/l
1.3
1.4
0.68
176
915
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
223
1212
1.99
18.11
7.7
7.4
kpa
5.0
5.1
0.23
208
1164
(3027801) Oxygen [Partial pressure] in Arterial blood
223
1212
1.99
18.11
7.7
7.4
kpa
12.0
12.4
0.45
208
1164
(3037756) Immunofixation for Serum or Plasma
68
211
3.33
18.07
1.4
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
222
1218
1.97
17.52
7.8
7.4
mmol/l
1.2
1.1
0.14
178
957
(3048689) Calprotectin [Mass/mass] in Stool
219
1199
1.98
17.38
2.4
2.3
ug/g
182.1
131.0
0.79
178
948
(3013826) Glucose [Moles/volume] in Serum or Plasma
814
6417
1.62
17.38
6.2
4.6
mmol/l
6.7
6.7
0.56
784
5981
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
87
320
2.83
17.28
3.0
2.2
g/l
0.7
1.2
0.55
81
279
(3034860) Kappa light chains.free [Mass/volume] in Serum
83
302
2.86
16.82
2.8
3.7
mg/l
51.4
223.4
0.46
64
252
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
83
304
2.84
16.62
2.8
3.7
mg/l
29.9
64.1
1.06
65
255
(3000494) Fungus identified in Specimen by Culture
214
1197
1.93
15.87
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
372
2457
1.69
15.81
1.7
1.5
nmol/l
21.9
20.6
0.95
333
2100
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
349
2276
1.70
15.51
2.0
1.9
mg/l
1.4
1.2
0.40
291
1727
(3007566) Smooth muscle Ab [Titer] in Serum
75
273
2.84
15.20
1.1
1.2
titre
66.3
70.5
—
8
22
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
148
3.54
15.06
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
210
1190
1.90
14.93
2.1
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
38
90
4.31
14.85
2.9
2.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1215
10795
1.82
14.74
21.9
11.7
ml/min/173m2
82.9
81.5
1.40
1067
8778
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
210
1195
1.89
14.73
2.1
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
231
1359
1.83
14.58
9.0
7.0
mmol/l
104.0
104.3
0.33
225
1332
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
36
83
4.42
14.56
1.3
1.1
titre
260.0
168.1
0.29
14
16
(40760888) Immunoglobulin light chains.free panel - Serum
64
222
2.97
14.15
2.1
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
456
3245
1.59
14.14
3.9
2.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
310
2008
1.69
13.95
2.9
3.0
mmol/l
2.5
2.5
0.30
255
1784
(3000991) Gas panel - Venous blood
168
905
1.97
13.85
9.4
8.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
464
3332
1.58
13.76
2.9
2.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
36
87
4.22
13.72
1.8
1.4
g/l
0.3
0.4
1.04
25
60
(3027135) IgG subclass 1 [Mass/volume] in Serum
36
87
4.22
13.72
1.8
1.4
g/l
6.4
7.2
0.40
25
60
(3028192) IgG subclass 2 [Mass/volume] in Serum
36
87
4.22
13.72
1.8
1.4
g/l
2.6
2.9
0.57
25
60
(3041096) Erythrocytes [Presence] in Urine by Automated
417
2930
1.60
13.53
5.1
3.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
231
1396
1.78
13.26
6.5
5.7
mmol/l
1.0
1.0
0.16
216
1292
(4062490)
36
90
4.08
13.13
1.9
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
539
4043
1.53
12.99
4.3
3.4
ng/l
389.1
64.6
0.44
380
2686
(3045414) Leukocytes [Presence] in Urine
93
414
2.33
12.50
1.9
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
65
244
2.74
12.46
4.2
3.6
mmol/l
25.6
25.2
0.23
52
222
(3005322) IgE [Units/volume] in Serum or Plasma
126
638
2.07
12.32
1.3
1.2
u/ml
165.5
221.2
0.50
119
580
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
459
3355
1.54
12.31
3.0
2.5
u/l
78.8
58.0
0.78
423
3093
(3033658) Prothrombin time (PT) actual/Normal
396
2803
1.57
12.25
5.0
3.8
%
91.6
90.5
0.40
387
2736
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
69
270
2.63
12.21
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
155
3.17
12.02
1.7
1.8
g/l
0.5
0.9
1.70
36
124
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
115
568
2.11
12.00
9.8
10.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
69
273
2.60
11.95
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
930
7898
1.50
11.83
4.2
3.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
213
1298
1.75
11.81
22.6
22.3
inr
1.5
1.4
0.56
44
181
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1326
12288
2.03
11.74
21.5
9.1
u/l
26.0
26.0
0.04
1312
11819
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
68
271
2.58
11.61
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
69
278
2.56
11.52
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
58
214
2.78
11.51
5.0
5.9
iu/ml
582.0
1013.4
—
6
38
(3021901) Oxygen saturation in Capillary blood
52
181
2.94
11.47
3.1
3.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
82
360
2.36
11.39
3.0
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
127
664
2.00
11.37
7.3
6.9
mmol/l
24.9
24.4
0.52
116
623
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
306
2077
1.60
11.20
4.2
3.4
ng/l
375.3
428.8
0.11
235
1565
(3018677) aPTT in Platelet poor plasma by Coagulation assay
256
1669
1.65
11.01
2.5
2.3
s
29.0
29.9
1.81
251
1622
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
353
2506
1.54
10.55
2.7
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
107
541
2.06
10.51
1.3
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
12
12
10.08
10.45
1.2
1.0
u/ml
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
44
150
2.99
10.09
1.2
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
46
161
2.92
10.08
3.5
3.9
%
0.8
1.4
0.76
39
129
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
141
796
1.86
10.04
3.3
2.6
ml/min/173m2
58.6
67.9
2.01
60
322
(3017732) Neutrophils [#/volume] in Blood
126
686
1.92
10.03
3.9
2.9
e9/l
4.8
4.1
2.08
108
548
(3019550) Sodium [Moles/volume] in Serum or Plasma
1278
11805
1.75
10.00
24.2
14.6
mmol/l
139.4
139.7
3.72
1252
11445
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
117
625
1.95
9.85
1.9
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
169
1014
1.76
9.84
4.5
4.0
mmol/l
2.1
1.8
0.37
139
794
(3012095) Magnesium [Moles/volume] in Serum or Plasma
262
1771
1.59
9.63
3.9
3.4
mmol/l
0.8
0.8
0.18
246
1662
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
24
6.31
9.00
1.2
1.2
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
13
7
18.72
8.94
1.2
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
71
327
2.23
8.87
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
28
78
3.64
8.85
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
44
162
2.77
8.82
1.7
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
156
945
1.73
8.76
8.7
7.6
mmol/l
10.8
9.4
1.58
149
896
(3023103) Potassium [Moles/volume] in Serum or Plasma
1275
11849
1.68
8.73
24.4
14.7
mmol/l
3.9
4.0
1.70
1247
11466
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
62
280
2.27
8.13
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
71
340
2.14
8.08
2.3
2.3
ug/l
212.3
1075.6
0.82
66
320
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
28
84
3.38
7.95
1.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
132
2.85
7.89
1.5
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
121
704
1.78
7.82
4.6
4.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
191
1257
1.60
7.78
2.7
2.9
umol/l
9.4
8.5
0.15
165
1102
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
64
300
2.19
7.69
1.4
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
161
1022
1.65
7.59
1.7
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
261
1852
1.50
7.57
1.6
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
176
1147
1.61
7.46
1.7
2.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
46
191
2.45
7.31
1.3
1.2
u/ml
341.4
251.2
1.18
26
114
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
150
2.64
7.24
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
38
4.52
7.18
1.4
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
95
528
1.86
7.14
1.3
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
140
871
1.67
7.13
3.6
2.9
ng/l
276.6
190.6
0.90
125
796
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
143
895
1.66
7.12
2.5
2.4
ug/l
4.5
6.8
1.85
127
783
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
176
2.49
7.05
1.5
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
128
782
1.70
6.98
4.2
3.8
ng/l
91.0
87.5
0.17
116
682
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
253
2.22
6.95
1.7
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
110
646
1.76
6.90
3.9
3.9
kpa
5.2
5.2
0.03
100
606
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
173
2.47
6.80
1.6
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
128
2.70
6.60
1.9
2.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
47
207
2.31
6.59
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
161
1059
1.59
6.56
4.2
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
79
426
1.90
6.53
2.2
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
61
300
2.08
6.53
1.6
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
21
60
3.54
6.45
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
52
243
2.18
6.35
1.7
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
10
15
6.71
6.31
1.4
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
73
388
1.93
6.31
2.1
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
218
2.24
6.28
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
48
218
2.24
6.28
1.3
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
143
925
1.61
6.25
5.1
3.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1083
9911
1.38
6.23
33.7
16.1
g/l
331.0
332.6
7.01
1077
9835
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
105
632
1.71
6.07
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1132
10452
1.39
6.04
5.1
4.5
mu/l
1.9
2.2
0.92
1046
9519
(3017704) Immunofixation for Urine
20
58
3.48
6.02
1.2
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
29
106
2.77
5.97
2.3
2.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
109
666
1.69
5.96
9.5
7.8
mmol/l
25.1
24.8
0.38
109
659
(3009343) pH of Capillary blood
106
644
1.70
5.92
4.0
3.9
ph
7.4
7.4
0.02
22
65
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
148
2.47
5.89
1.2
1.3
u/ml
4.5
5.0
0.06
16
55
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
36
4.20
5.83
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
143
2.48
5.81
1.2
1.3
u/ml
3.2
4.1
0.28
13
72
(40761511) CBC panel - Blood by Automated count
1270
11996
1.51
5.78
20.9
11.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
75
3.10
5.78
1.9
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
103
626
1.70
5.75
3.7
3.9
mmol/l
2.8
1.9
1.50
81
471
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
28
4.68
5.74
2.7
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
88
512
1.77
5.74
2.4
2.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
17
5.92
5.63
3.6
3.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
71
3.13
5.63
2.1
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
154
1040
1.54
5.60
2.8
2.4
u/l
33.4
42.2
1.48
120
890
(3005011) Chlamydia sp Ab [Titer] in Serum
9
7
12.93
5.58
1.2
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
39
174
2.28
5.36
1.6
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
76
433
1.80
5.33
4.0
5.5
%
1.7
1.6
0.37
70
406
(3009871) Measles virus Ab [Titer] in Serum
13
30
4.36
5.30
1.8
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
151
1030
1.52
5.25
2.5
2.3
g/l
0.2
0.2
0.04
141
970
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
74
422
1.79
5.19
1.0
1.1
—
2.0
—
0
6
(3007930) Methemoglobin/Hemoglobin.total in Blood
75
430
1.79
5.16
4.0
5.6
%
0.9
0.9
0.20
69
404
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
139
2.41
5.16
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
807
7181
1.28
5.06
3.2
2.9
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
60
324
1.89
5.00
2.5
2.9
%
200.9
189.7
0.34
52
312
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
47
233
2.05
4.99
1.9
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
36
3.92
4.99
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
333
1.87
4.93
3.1
3.9
u/ml
0.4
0.4
0.10
37
186
(3000570) Elastase.pancreatic [Mass/mass] in Stool
54
283
1.94
4.92
1.3
1.5
ug/g
293.5
269.3
0.41
33
167
(3043409) Potassium [Moles/volume] in Arterial blood
60
327
1.87
4.87
5.3
3.6
mmol/l
3.8
3.9
0.34
54
309
(3024731) MCV [Entitic volume]
1346
12947
1.63
4.87
38.3
18.2
fl
91.8
90.8
11.49
1336
12707
(3035941) MCH [Entitic mass]
1346
12949
1.63
4.84
38.2
18.2
pg
30.4
30.3
2.60
1335
12708
(3026361) Erythrocytes [#/volume] in Blood
1346
12950
1.63
4.83
38.5
18.3
e12/l
4.4
4.5
17.39
1325
12509
(3007461) Platelets [#/volume] in Blood
1345
12939
1.62
4.81
38.6
18.3
e9/l
260.9
251.1
5.78
1327
12528
(3010813) Leukocytes [#/volume] in Blood
1346
12953
1.62
4.78
38.5
18.3
e9/l
7.1
6.6
4.34
1325
12509
(3000963) Hemoglobin [Mass/volume] in Blood
1346
12954
1.62
4.77
38.7
18.4
g/l
132.0
135.4
14.53
1334
12713
(3024891) Influenza virus A+B Ag [Presence] in Specimen
54
287
1.92
4.74
1.1
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
204
2.09
4.72
2.9
2.5
g/l
127.6
128.8
0.10
35
144
(40768443) Skin Pathology biopsy report
73
427
1.75
4.72
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
124
830
1.54
4.71
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
133
2.36
4.68
2.4
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1115
10398
1.32
4.62
6.4
5.3
mmol/mol
39.1
39.7
1.72
1054
9561
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
130
885
1.52
4.58
3.9
3.6
mmol/l
1.2
1.2
0.03
121
750
(44790048)
28
116
2.44
4.57
1.9
1.4
—
—
—
0
0
(44790049)
28
116
2.44
4.57
1.9
1.4
—
—
—
0
0
(44790047)
28
116
2.44
4.57
1.9
1.4
—
—
—
0
0
(44806118)
28
116
2.44
4.57
1.9
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
192
1412
1.42
4.55
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
235
1.99
4.53
1.2
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
83
510
1.67
4.50
4.8
4.7
mmol/l
24.0
24.0
0.07
77
463
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
953
8724
1.27
4.45
4.3
3.9
pmol/l
14.7
14.7
0.08
863
7909
(3012516) Albumin [Mass/volume] in Urine
384
3155
1.30
4.38
3.6
3.2
mg/l
459.3
311.9
0.28
268
1963
(3032773) Endomysium IgG Ab [Titer] in Serum
23
89
2.61
4.32
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
115
2.37
4.17
1.4
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
33
154
2.17
4.14
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
98
642
1.57
4.12
4.5
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
828
7490
1.25
4.11
3.7
3.0
u/l
58.1
47.6
1.77
775
6987
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
42
218
1.95
3.99
1.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
528
4557
1.25
3.95
2.2
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
106
2.38
3.91
1.6
1.7
—
—
—
0
0
(4268621)
24
100
2.42
3.90
2.0
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
42
220
1.94
3.90
3.7
3.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
24
4.19
3.89
1.0
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
65
2.79
3.86
2.4
3.3
%
37.7
39.8
—
6
20
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
107
2.36
3.84
1.5
1.8
—
—
—
0
0
(3000492) Spirometry study
142
1023
1.43
3.79
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
397
3332
1.26
3.75
4.4
3.9
mg/mmol
18.5
8.6
1.68
275
2102
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
78
2.59
3.72
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
40
210
1.93
3.70
1.6
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
197
1.95
3.65
3.3
2.4
%
16.7
16.3
0.23
27
92
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
79
2.55
3.64
2.0
2.3
%
10.9
13.7
—
10
33
(3024928) Oxygen saturation in Venous blood
43
233
1.87
3.63
4.8
3.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
23
98
2.37
3.58
2.6
2.6
e9/l
1.3
1.1
0.52
15
63
(3020891) Body temperature
69
431
1.63
3.57
6.7
4.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
400
3377
1.26
3.57
3.6
3.1
mmol/l
7.0
7.5
1.61
348
2857
(3012441) Differential panel - Pleural fluid
25
111
2.27
3.56
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
56
333
1.71
3.49
4.8
6.7
mmol/l
1.5
1.4
0.33
46
289
(3000093) Morphology [Interpretation] in Blood Narrative
20
81
2.49
3.47
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
133
2.13
3.41
1.6
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1125
10631
1.27
3.39
27.3
13.7
%
39.0
39.7
1.82
808
7764
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
39
210
1.88
3.37
1.4
1.5
—
20.2
—
0
6
(3026250) Tacrolimus [Mass/volume] in Blood
13
42
3.11
3.37
31.2
28.8
ug/l
6.8
7.2
0.26
13
35
(3002619) Bacteria identified in Specimen by Culture
7
10
7.03
3.36
2.6
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
31
155
2.02
3.31
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
54
2.80
3.26
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
66
418
1.61
3.26
2.3
2.4
s
21.6
21.6
0.02
57
378
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
38
3.18
3.21
3.5
3.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
49
288
1.73
3.21
1.1
1.1
u/ml
4.7
4.0
—
8
39
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
28
3.59
3.20
1.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
49
2.88
3.19
1.9
3.3
—
—
—
0
0
(3013512) EKG study
363
3067
1.25
3.17
4.5
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
171
1311
1.35
3.16
1.9
1.7
%
1.7
1.4
2.52
136
1172
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
55
2.75
3.16
1.8
1.4
u/l
3.8
8.1
—
9
25
(3045142) Bone marrow Pathology biopsy report
27
131
2.08
3.13
1.1
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
20
4.52
3.11
1.3
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
8
7.53
3.05
1.3
1.5
ng/l
91.5
89.0
—
6
8
(3039000) Anion gap in Blood
42
241
1.77
3.00
5.2
7.5
mmol/l
10.6
11.3
0.57
36
216
(3022145) Colonoscopy Study observation
155
1182
1.35
2.98
1.4
1.3
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
5
10.03
2.98
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
75
2.42
2.97
1.1
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
42
242
1.76
2.96
5.2
7.5
mmol/l
105.0
105.3
0.14
36
217
(3000330) Specific gravity of Urine by Test strip
77
518
1.51
2.95
3.3
3.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
30
3.35
2.91
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
35
192
1.84
2.90
2.9
2.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
9
6.69
2.87
1.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
40
230
1.76
2.85
3.0
3.3
umol/l
31.8
35.9
0.67
32
189
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
168
1309
1.32
2.80
10.6
6.4
—
—
—
0
0
(4010399)
102
735
1.42
2.77
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
58
375
1.57
2.68
2.9
3.4
g/l
0.4
0.2
0.42
33
161
(3014051) Protein [Presence] in Urine by Test strip
36
205
1.78
2.67
2.2
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
29
155
1.89
2.62
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
99
1343
0.72
2.62
4.4
4.2
%
32.7
32.8
0.03
74
879
(3047189) Immunofixation for 24 hour Urine
14
55
2.56
2.62
2.0
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
277
2318
1.24
2.61
1.7
1.6
pmol/l
54812178.6
42380386.2
0.12
239
1916
(3035637) Corticotropin [Mass/volume] in Plasma
25
127
1.99
2.61
1.2
1.5
—
—
—
0
0
(4306422)
28
149
1.90
2.57
1.3
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
56
2.51
2.53
1.4
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
150
1.88
2.52
1.0
1.0
u/ml
3.4
2.2
0.38
12
68
(3036048) Francisella tularensis Ab [Titer] in Serum
9
26
3.48
2.48
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
109
2.03
2.47
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
116
2.00
2.46
3.0
4.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
57
2.47
2.45
1.4
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
33
189
1.76
2.42
1.5
1.5
u/ml
103.1
110.3
—
10
32
(3027456) Digoxin [Moles/volume] in Serum or Plasma
33
189
1.76
2.42
2.7
3.2
nmol/l
0.8
0.8
0.12
25
143
(44813793)
16
70
2.30
2.41
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
77
2.22
2.38
1.8
2.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
22
3.65
2.36
1.1
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
57
379
1.52
2.36
2.2
2.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
105
2.01
2.31
3.2
3.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
148
1.84
2.29
1.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
12
47
2.57
2.27
1.5
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
228
1899
1.24
2.25
1.4
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
135
1.87
2.23
1.6
1.4
e6/l
2866.2
1904.6
0.48
19
101
(3003181) Sodium [Moles/volume] in Urine
34
202
1.70
2.22
1.4
1.4
mmol/l
55.2
59.2
0.27
25
165
(43055442) Apixaban [Mass/volume] in Serum or Plasma
5
9
5.57
2.21
1.2
1.7
ug/l
88.4
161.3
—
5
9
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
24
3.35
2.18
1.1
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
14
4.30
2.15
2.3
3.4
u/field
0.5
0.4
—
6
14
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
30
3.01
2.15
1.0
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
123
1.88
2.12
1.3
1.3
e6/l
34958.8
64505.2
0.45
16
79
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
102
1.97
2.11
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
102
1.97
2.11
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
102
1.97
2.11
1.5
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
138
1.83
2.10
1.2
1.4
nmol/l
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
103
1.96
2.05
1.1
2.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
20
3.51
2.05
1.7
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
24
132
1.83
2.04
1.2
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
10
38
2.64
2.01
1.1
1.1
u/ml
0.1
1.2
—
5
19
(3000012) Reticulocyte production index
13
57
2.29
1.98
2.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
21
112
1.89
1.96
1.4
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
64
2.20
1.94
1.3
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
67
482
1.41
1.91
3.7
3.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
92
1.97
1.90
1.2
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
22
3.19
1.88
1.0
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
34
2.66
1.86
1.3
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
100
1.91
1.86
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
79
2.04
1.85
1.4
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
383
4279
0.86
1.84
2.8
2.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
20
108
1.86
1.82
3.9
3.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
101
1.89
1.81
2.9
3.9
%
65.8
59.1
0.60
12
64
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
73
2.07
1.81
1.5
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
80
2.01
1.80
1.3
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
35
2.58
1.80
1.4
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
29
177
1.65
1.77
1.4
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
41
2.45
1.75
1.2
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
257
1.53
1.74
1.3
1.7
e6/l
13.2
9.0
0.23
34
199
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
257
1.53
1.74
1.3
1.8
e6/l
219.1
869.8
0.95
34
210
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
13
3.86
1.71
19.6
5.9
mmol/l
5.6
6.4
—
5
13
(3008401) Mugwort IgE Ab [Units/volume] in Serum
29
179
1.63
1.70
1.1
1.1
u/ml
0.4
1.0
1.29
16
75
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
284
1.49
1.68
1.4
1.4
u/l
12.0
10.3
0.31
37
226
(3032057) Clostridioides difficile [Presence] in Stool
6
19
3.17
1.66
4.0
1.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
25
2.81
1.65
1.4
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
112
1.80
1.65
1.7
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
12
56
2.15
1.61
1.2
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
36
238
1.53
1.61
3.7
3.8
kpa
8.1
8.6
1.25
36
231
(3014599) Egg white IgE Ab [Units/volume] in Serum
13
63
2.07
1.60
1.1
1.0
u/ml
0.3
0.5
—
7
18
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
136
1.70
1.59
1.3
1.4
pmol/l
218.8
304.7
1.01
17
107
(3013290) Carbon dioxide [Partial pressure] in Blood
36
239
1.52
1.58
3.7
3.8
kpa
4.8
5.1
1.62
36
233
(3012501) Base excess in Blood by calculation
36
239
1.52
1.58
3.7
3.8
mmol/l
2.1
2.5
0.65
25
171
(4094501)
41
280
1.48
1.58
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
114
1.77
1.57
1.3
2.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
92
1.86
1.56
1.3
1.2
u/ml
0.0
0.3
—
9
49
(3002256) Pathology report gross observation
176
1486
1.21
1.56
1.3
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
87
677
1.30
1.55
2.7
3.3
pmol/l
4.3
4.5
1.76
78
609
(3019977) pH of Arterial blood
12
57
2.11
1.55
2.7
3.9
ph
7.4
7.4
—
7
20
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
216
1.54
1.55
1.1
1.1
u/ml
1.0
3.1
1.23
15
84
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
33
2.43
1.54
1.8
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
41
282
1.47
1.53
3.7
4.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
162
1.62
1.50
1.1
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
57
419
1.38
1.49
3.4
3.6
u/ml
409.5
3313.5
0.66
48
364
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
332
2971
1.15
1.47
1.7
1.6
mmol/l
1.4
1.4
0.55
276
2479
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
25
155
1.62
1.47
1.0
1.1
g/l
1.5
1.4
0.19
25
143
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
45
2.23
1.46
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
140
1.65
1.45
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
80
1.88
1.45
1.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
16
3.13
1.44
2.2
8.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
22
2.73
1.43
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
110
1.74
1.43
1.9
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
53
2.08
1.38
1.4
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
28
182
1.55
1.38
1.1
1.1
u/ml
7.0
4.8
0.33
17
87
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
23
2.62
1.37
1.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
23
2.62
1.37
1.2
1.7
ug/l
9.8
8.3
—
6
23
(40757373) Influenza virus identified in Isolate
6
23
2.62
1.37
1.8
1.9
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
112
1.71
1.35
1.2
2.0
—
—
—
0
0
(4034850)
54
401
1.36
1.35
16.9
8.4
—
—
—
0
0
(3010421) pH of Blood
41
291
1.42
1.33
3.8
3.7
ph
7.4
7.4
1.33
36
233
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
54
2.05
1.33
1.4
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
43
2.10
1.30
2.0
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
33
226
1.47
1.29
3.4
2.9
mmol/l
7.7
7.8
0.08
33
220
(40768793) Breast Pathology biopsy report
19
305
0.62
1.28
1.6
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
18
2.78
1.28
1.2
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
18
2.78
1.28
1.2
1.2
—
9.1
—
0
5
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1147
11145
1.14
1.28
4.7
4.2
mmol/l
5.9
5.9
0.31
1052
10143
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
69
537
1.30
1.27
1.7
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
11
55
2.01
1.27
1.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
44
2.05
1.27
1.6
2.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
9
44
2.05
1.27
1.6
2.1
%
6.3
6.8
—
9
44
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
89
1097
0.80
1.26
1.8
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
54
406
1.34
1.26
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
34
481
0.70
1.26
1.7
1.7
mg/l
2.9
4.2
0.41
25
332
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1164
11328
1.15
1.24
4.6
4.1
mmol/l
1.5
1.5
0.30
1083
10404
(3010503) CD19 cells [#/volume] in Blood
12
63
1.91
1.23
2.8
2.7
e9/l
0.1
0.1
0.16
12
63
(3017315) Amylase [Enzymatic activity/volume] in Urine
11
56
1.97
1.22
1.7
1.3
u/l
757.1
485.0
0.19
11
48
(3044242) Glucose [Moles/volume] in Arterial blood
10
49
2.05
1.22
1.5
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1172
11415
1.15
1.21
4.6
4.2
mmol/l
4.7
4.7
0.96
1101
10556
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
37
2.17
1.21
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
78
1.80
1.21
4.1
3.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
32
222
1.45
1.19
1.2
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
57
1.94
1.17
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
96
1160
0.82
1.15
1.2
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
367
3360
1.12
1.15
4.8
4.8
ug/l
2.2
3.0
1.52
325
2998
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
24
158
1.53
1.15
1.8
2.6
u/ml
6.3
7.2
0.11
24
149
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1123
10920
1.13
1.14
4.2
3.7
mmol/l
1.3
1.3
2.60
1043
9972
(3019225) pH of Specimen
125
1057
1.20
1.14
3.8
4.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
80
1.76
1.13
1.2
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
167
1.51
1.12
2.3
1.4
nmol/l
0.5
0.3
0.48
19
132
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
16
96
1.67
1.10
1.2
1.0
mg/l
271.6
293.0
0.51
16
85
(3008037) Lactate [Moles/volume] in Venous blood
34
243
1.41
1.10
3.3
2.8
mmol/l
1.6
1.6
0.09
34
237
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
256
0.62
1.10
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
256
0.62
1.10
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
280
0.64
1.09
1.3
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
350
3206
1.12
1.09
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
120
1.59
1.08
1.8
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
120
1.59
1.08
1.8
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
255
0.62
1.08
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
32
2.19
1.08
4.1
2.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
89
1.69
1.07
1.5
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
11
59
1.87
1.07
1.1
1.1
u/ml
0.2
0.4
—
5
19
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
254
0.63
1.07
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
121
1.58
1.05
1.8
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
121
1.58
1.05
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
121
1.58
1.05
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
121
1.58
1.05
1.8
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
46
1.96
1.03
1.1
3.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
146
1.51
1.03
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
47
359
1.32
1.03
2.1
2.3
u/l
4967.8
3791.1
0.10
21
164
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
215
0.60
1.03
1.4
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
39
290
1.35
1.02
2.0
2.0
iu/l
3.1
5.0
1.03
13
109
(3028433) Virus identified in Specimen by Culture
7
35
2.00
1.00
1.0
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
107
1.60
1.00
2.6
2.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
49
1.84
0.98
1.2
1.0
miu/ml
1210.0
1629.6
—
9
49
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
23
2.18
0.98
1.6
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
82
677
1.22
0.98
2.1
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
132
1.52
0.97
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
50
1.80
0.96
1.1
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
45
346
1.31
0.96
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
210
0.62
0.95
1.4
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
37
1.90
0.94
1.1
2.2
—
—
—
0
0
(3024471) HLA-A [Type]
7
37
1.90
0.94
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
27
2.23
0.93
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
95
801
1.20
0.93
1.2
1.2
iu/ml
142.4
156.6
0.13
33
293
(3015183) Erythrocyte sedimentation rate
9
52
1.74
0.92
1.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
208
0.62
0.92
1.4
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
55
1.82
0.92
1.4
2.4
u/l
244.7
192.1
—
10
55
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
55
1.82
0.92
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
28
2.15
0.91
2.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
28
2.15
0.91
1.8
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
63
1.75
0.90
1.6
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
63
1.75
0.90
1.5
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
63
1.75
0.90
1.6
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
63
1.75
0.90
1.6
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
63
1.75
0.90
1.6
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
143
1.48
0.90
2.2
2.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
43
1.87
0.87
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
64
1.72
0.86
1.5
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
64
1.72
0.86
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
112
1.52
0.85
1.4
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
31
1.94
0.84
1.7
3.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
1.3
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
44
345
1.28
0.83
1.4
1.2
miu/ml
199.8
259.9
0.56
27
159
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
138
0.58
0.83
2.1
1.8
—
1382.9
—
0
7
(40768800) Prostate Pathology biopsy report
14
214
0.65
0.83
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
65
1.70
0.82
1.1
1.1
—
—
—
0
0
(4211845)
6
32
1.88
0.82
1.7
3.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
36
464
0.77
0.80
1.3
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1185
11625
1.11
0.80
5.1
4.6
mmol/l
2.7
2.8
1.84
1103
10679
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
33
1.82
0.79
1.2
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.0
1.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
25
0.00
0.79
0.0
3.7
—
—
—
0
0
(4035726)
121
1059
1.16
0.79
1.4
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
26
0.00
0.78
0.0
3.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
90
1.56
0.78
1.7
4.0
%
9.1
11.3
1.42
14
90
(4133840)
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
159
1.39
0.72
1.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
28
1.79
0.66
2.2
2.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
62
1.62
0.65
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
62
1.62
0.65
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
29
1.73
0.64
4.2
3.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
29
1.73
0.64
4.2
3.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.7
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.8
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
49
1.64
0.62
1.7
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
262
1.27
0.61
4.9
3.5
mg/l
23.2
26.4
0.28
24
163
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
105
1.43
0.60
1.1
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
12
80
1.50
0.60
1.0
1.0
ng/l
762.3
634.1
—
6
49
(44816559) Phosphatidylethanol [Mass/volume] in Blood
24
183
1.32
0.59
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
162
0.68
0.58
1.5
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
12
81
1.49
0.57
1.0
1.0
ng/l
232.0
290.1
—
6
51
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
141
1.35
0.56
1.3
1.3
mmol/l
6.4
7.4
0.67
13
107
(3024932) HLA-DR beta [Type]
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
37
1.62
0.55
1.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
37
1.62
0.55
2.3
2.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
251
0.75
0.55
3.8
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
60
1.50
0.54
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
21
160
1.32
0.53
1.8
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
23
178
1.30
0.53
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
178
1.30
0.53
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
64
736
0.86
0.52
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
205
1.27
0.52
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
10
66
1.52
0.52
1.0
1.1
iu/ml
8.8
12.7
—
5
21
(3005570) Glucose [Moles/volume] in Urine
16
117
1.37
0.52
2.9
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
37
305
1.22
0.52
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
14
100
1.40
0.52
2.0
2.2
mg/l
10.5
21.8
—
6
35
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
12
83
1.45
0.52
1.0
1.0
ng/l
32.5
45.4
—
6
50
(3050129) First trimester maternal screen panel - Serum or Plasma
24
303
0.79
0.51
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
115
1041
1.11
0.50
1.6
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
33
271
1.22
0.49
2.0
2.4
ug/min
146.5
156.8
0.05
16
169
(4146454)
7
109
0.64
0.48
3.0
2.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
222
0.76
0.47
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
49
1.43
0.46
1.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
49
1.43
0.46
1.0
1.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
174
1.27
0.45
1.1
1.1
u/ml
0.4
3.4
—
7
41
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
86
1.40
0.44
1.8
1.4
g/l
0.9
1.0
0.12
12
86
(44806420)
5
31
1.61
0.43
1.8
2.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
56
1.43
0.42
1.5
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
16
122
1.31
0.42
1.0
1.0
u/ml
0.1
0.4
—
5
27
(3020650) Glucose [Presence] in Urine
5
32
1.56
0.42
4.0
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
48
416
1.16
0.42
3.6
4.0
mmol/l
25.4
24.8
0.99
41
389
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
58
1.38
0.41
1.1
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
33
1.52
0.41
15.6
8.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
79
1.40
0.40
1.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
17
0.00
0.40
0.0
5.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
17
0.00
0.40
0.0
3.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
18
0.00
0.40
0.0
2.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
35
1.43
0.39
1.2
3.5
—
1070.1
—
0
8
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
133
1.28
0.38
1.1
1.1
u/ml
1.7
6.7
—
7
48
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
80
1.38
0.38
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
286
2728
1.06
0.38
4.5
4.2
%
23.0
22.1
0.49
141
1350
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
112
0.71
0.37
1.5
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
57
640
0.89
0.37
1.7
1.7
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
9
70
1.29
0.36
1.8
1.3
mmol/l
28.8
32.6
—
9
61
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
42
1.43
0.35
1.7
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
48
423
1.14
0.35
1.7
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
103
951
1.09
0.34
1.3
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
18
145
1.24
0.33
1.1
1.1
u/ml
2.1
3.5
—
10
49
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
199
0.80
0.33
2.2
1.7
—
—
—
0
0
(1002224) Polysomnography panel
50
445
1.13
0.32
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
579
1.11
0.32
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
92
1.31
0.32
1.7
2.4
u/field
2.7
1.7
—
7
38
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
211
1.19
0.31
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
128
1201
1.07
0.30
1.5
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
141
0.78
0.29
1.1
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
56
1.25
0.29
1.1
1.1
nmol/l
132.0
130.0
—
7
56
(3013139) Helicobacter pylori Ag [Presence] in Stool
78
720
1.09
0.27
1.2
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
30
262
1.15
0.26
1.6
1.5
pmol/l
212.7
212.0
0.00
30
257
(4027681)
8
67
1.20
0.26
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
56
512
1.10
0.25
1.3
1.4
iu/l
23.8
31.6
1.07
46
424
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
388
1.11
0.24
1.6
1.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
10
78
1.28
0.24
1.1
1.1
mg/l
175.0
285.6
—
10
69
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
38
1.32
0.23
2.4
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
10.2
—
0
5
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
6.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
8.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
125
1192
1.05
0.20
3.4
4.4
ug/l
11.1
23.8
0.64
102
994
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
202
1950
1.04
0.20
3.2
2.9
ug/l
0.7
0.8
0.86
138
1268
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
72
1.11
0.16
1.9
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
193
0.88
0.15
2.2
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
77
0.78
0.15
1.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
121
1.16
0.15
2.1
2.6
—
—
—
0
0
(4024509)
9
82
1.10
0.15
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
285
1.09
0.14
2.5
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
104
1.16
0.12
3.3
4.0
u/ml
21.7
49.6
1.07
12
104
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
115
1.13
0.10
1.1
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
48
1.04
0.09
1.8
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
36
343
1.05
0.07
2.3
1.6
—
—
—
0
0
(4281824)
11
122
0.90
0.07
1.3
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
130
0.92
0.04
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
36
373
0.96
0.04
2.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
36
373
0.96
0.04
2.3
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
36
369
0.97
0.02
2.3
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
113
1.06
0.02
1.3
1.4
ug/l
2.4
2.9
0.33
12
97
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
136
1.03
0.00
1.2
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
20
202
0.99
0.00
1.0
1.1
iu/ml
125.1
2742.3
—
7
47
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
277
1.01
0.00
1.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
37
375
0.99
0.00
2.2
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
155
1.03
0.00
2.8
1.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
1.0
1.7
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
61
0.98
0.00
1.3
1.3
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.4
—
0
5
(3004959) Base excess in Arterial cord blood by calculation
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
3.6
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
32.8
—
0
5
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
5.8
11.6
mmol/l
0.6
0.7
—
6
60
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
14.4
—
0
6
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
8.5
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint M13_POLYARTHRITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POLYARTHRITIS | 1.314 [1.18, 1.47] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.072 |
During the follow-up period (1.1.1998 — 31.12.2019), 742 out of 3877 females with M13_POLYARTHRITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_POLYARTHRITIS | 1.534 [1.36, 1.73] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 723 out of 2820 males with M13_POLYARTHRITIS died.
Mortality risk
Mortality risk for people of age
years, who have M13_POLYARTHRITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | 0.25% |
| 5 | 0.742% | 1.823% |
| 10 | 1.726% | 4.371% |
| 15 | 3.488% | 8.113% |
| 20 | 6.128% | 13.419% |
Relationships between endpoints
↥Index endpoint: M13_POLYARTHRITIS – Polyarthritis, unspecified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data